Related Experiment Video
Updated: Jan 7, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Reducing Acute Kidney Injury in Critically Ill Pediatric Patients: Quality Improvement Project Targeting Nephrotoxic
Natalie Capretta1, Diana Zepeda-Orozco2,3,4, W Joshua Frazier1
1Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH.
Insights
A quality improvement initiative reduced acute kidney injury (AKI) in critically ill children exposed to nephrotoxic medications (NTM). Pharmacist-led education and daily alerts significantly lowered NTM exposure and NAKI rates.
Area of Science:
- Pediatric Critical Care Medicine
- Nephrology
- Quality Improvement Science
Background:
- Nephrotoxic medications (NTM) are a significant risk factor for acute kidney injury (AKI) in critically ill pediatric patients.
- Structured interventions are needed to mitigate NTM-associated AKI (NAKI) in the pediatric intensive care unit (PICU).
Purpose of the Study:
- To decrease the incidence of AKI resulting from nephrotoxic medication exposure in critically ill children.
- To implement and evaluate a quality improvement (QI) initiative targeting NTM use in the PICU.
Main Methods:
- A prospective, multi-phased QI project was conducted at a quaternary care children's hospital.
- Interventions included pharmacist-led education, informational handouts, and daily clinical pharmacist notifications of NTM exposure.
- Data on NTM exposure and NAKI rates were collected pre- and post-intervention.
Main Results:
- NTM exposure rates decreased by 12.4% (30.6 to 26.9 per 1000 patient-days).
- NTM-associated AKI (NAKI) rates saw a significant reduction of 55% (5.6 to 2.5 per 1000 patient-days).
- The study included 34,631 patient-days over a 20-month period.
Conclusions:
- Targeted QI interventions, including education and pharmacy alerts, effectively reduced NTM exposure and NAKI in critically ill pediatric patients.
- Pharmacy-driven notifications and stakeholder education are key components for NTM stewardship.
- Ongoing efforts focus on institutional integration and sustainability of these successful strategies.
Objective:
To reduce acute kidney injury (AKI) associated with nephrotoxic medication (NTM) exposure in critically ill pediatric patients through a structured quality improvement (QI) initiative.
Design:
Prospective, multi-phased QI project.
Setting:
A single-center, free-standing, quaternary care children's hospital.
Patients:
All patients admitted to the PICU during the study period.
Interventions:
A three-phase intervention strategy was implemented to increase awareness surrounding NTM exposures in PICU and their role in subsequent AKI development. Phase 1 introduced monthly pharmacist-led educational session for resident physicians. Phase 2 incorporated an informational handout reviewed during monthly resident orientations. In phase 3, clinical pharmacists provided daily notifications to attending physicians for patients meeting NTM exposure criteria, offering timely alternatives and AKI monitoring recommendations.
Measurements And Main Results:
NTM exposure and NTM-associated AKI (NAKI) rates per 1000 patient-days were measured across pre-intervention and post-intervention periods. From May 1, 2021, to December 31, 2023, a total of 34,631 patient-days were included. During this period, 2410 and 388 patient-days, respectively, satisfied NTM exposure and NAKI criteria. This accounted for 1039 NTM exposure events in 742 patients and 159 NAKI episodes in 125 unique patients. Following interventions, NTM exposure rates declined from 30.6 to 26.9 per 1000 patient-days (a 12.4% reduction), and NAKI rates decreased from 5.6 to 2.5 per 1000 patient-days (a 55% reduction).
Conclusions:
Targeted PICU-specific interventions, including routine stakeholder education and pharmacy-driven daily provider notifications, were associated with reductions in NTM exposure and subsequent NAKI rates in critically ill patients. Efforts to integrate and sustain these strategies at the institutional level are currently in progress.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology

